Cargando…
ClinicalTrials.gov as a Source of Information About Expanded Access Programs: Cohort Study
BACKGROUND: ClinicalTrials.gov (CT.gov) is the most comprehensive internet-based register of different types of clinical studies. Expanded access is the use of unapproved drugs, biologics, or medical devices outside of clinical trials. One of the key problems in expanded access is the availability t...
Autores principales: | Borysowski, Jan, Górski, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8587192/ https://www.ncbi.nlm.nih.gov/pubmed/34709189 http://dx.doi.org/10.2196/26890 |
Ejemplares similares
-
Characterization of Informed Consent Forms Posted on ClinicalTrials.gov
por: Tse, Tony, et al.
Publicado: (2021) -
Some data quality issues at ClinicalTrials.gov
por: Chaturvedi, Neha, et al.
Publicado: (2019) -
Obstacles to the reuse of study metadata in ClinicalTrials.gov
por: Miron, Laura, et al.
Publicado: (2020) -
Characteristics of Depression Clinical Trials Registered on ClinicalTrials.gov
por: Liang, Juan, et al.
Publicado: (2022) -
Characterization of key information sections in informed consent forms posted on ClinicalTrials.gov
por: Gelinas, Luke, et al.
Publicado: (2023)